BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

After the sell-out success of BioTrinity 2023, OBN are pleased to announce the 2024 edition will be hosted in a larger capacity venue, Convene 133 Houndsditch in London. The move will allow us to deliver an enhanced format, in a more spacious environment, whilst ensuring we continue to catalyse success for all who attend.

Event Link here.